New hope for kids with rare calcium disease: encaleret trial launches

NCT ID NCT07080385

First seen Jan 23, 2026 · Last updated May 14, 2026 · Updated 11 times

Summary

This study tests a drug called encaleret in children (birth to 17 years) with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic condition causing low blood calcium and high urine calcium. The goal is to see if the drug can safely normalize calcium levels. About 28 participants will receive the drug, and researchers will measure calcium in blood and urine, along with other markers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's National Medical Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Nemours Children's Health

    RECRUITING

    Jacksonville, Florida, 32207, United States

  • Royal London Hospital

    RECRUITING

    London, E1 1FR, United Kingdom

  • Royal Manchester Children's Hospital

    RECRUITING

    Manchester, M13 9WL, United Kingdom

  • The Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Yale University

    RECRUITING

    New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.